Factors affecting treatment adherence in a tuberculosis population in Calcutta, India

  • 27 Pages
  • 4.21 MB
  • English
The Physical Object
Pagination27 leaves
ID Numbers
Open LibraryOL19315710M


Details Factors affecting treatment adherence in a tuberculosis population in Calcutta, India FB2

The study was cross-sectional and Factors affecting treatment adherence in a tuberculosis population in Calcutta designed to determine factors that contribute to non-adherence to the anti-TB treatment. In this study, we defined non-adherence as any patient belonging to either intensive or continuation phase of either category I or II who missed one week of treatment in a month (either consecutive or sporadic doses totaling a week).Cited by: Barriers to treatment adherence of tuberculosis patients: A qualitative study in West Bengal, India Article (PDF Available) January with Reads How we measure 'reads'.

Factors affecting tuberculosis retreatment defaults in Nanded, India Article (PDF Available) in The Southeast Asian journal of tropical medicine and public health 41(5) September   India has more tuberculosis (TB) cases annually than any other country globally, India book an estimated disease prevalence of /, population, incidence of /, and deaths of 26/, Nationwide annual risk of TB infection (ARTI) surveys had estimated an ARTI of % (in –) and % (in –), with an average annual Cited by: The objective of this study was to assess of factors affecting adherence of pediatric TB patients to anti TB drugs in Adama referral hospital.

Methodology: Retrospective cross sectional study has been conducted from March th. to May th, to assess factors affecting adherence of pediatrics TB patients to anti TB drugs in Adama File Size: KB.

Treatment adherence is a complex behavioral issue and improving treatment outcomes for tuberculosis (and for other diseases) requires a full understanding of the factors that prevent people taking. Treatment of Latent Tuberculosis Infection: Maximizing Adherence. What You Need to Know About Your Medicine for Latent Tuberculosis (TB) Infection-Fact Sheet Series.

Isoniazid-specific Regimen. Rifampin-specific Regimen. Isoniazid and Rifapentine-specific Regimen. Page last reviewed: May 4, Content source: Division of Tuberculosis.

served Treatment Short Course (DOTS) global strategy, and was known as the “Revised Na-tional Tuberculosis Control Programme (RNTCP)” India is currently the second larg-est DOTS provider in the world Poor patient adherence to the treatment regi-men is a major cause of treatment failure and of the emergence of drug-resistant TB.

The World Health Organisation (WHO) TB statistics for India for give an estimated incidence figure of million cases.

Download Factors affecting treatment adherence in a tuberculosis population in Calcutta, India FB2

The TB incidence is the number of new cases of active TB disease during a certain time period (usually a year). The TB incidence figure for India is interim pending the results from the national TB prevalence survey. conducted to assess risk factors for non-compliance of hypertensive patients in field prac-tice area of Rural Health Training Centre (RHTC), Cherlapally, Nalgonda district, in Telangana state, which is in the southern part of India.

RHTC covers a population of 1, spread out in 11 villages. The study subjects comprised of hy. INTRODUCTION. Despite the availability of a cost-effective treatment, tuberculosis (TB) is still a major public health burden in developing countries Argentina, TB affects around 9, people (25 cases perpeople) and causes deaths every year Treatment adherence is considered a key component for disease control since treatment disruption may result in Cited by: Background: The Tuberculosis (TB) control program in Bangladesh is still unsatisfactory due to insufficient knowledge and stigma about TB.

Patients with low knowledge may be at higher risk of experiencing delays in diagnosis and appropriate ives: The aims of this study were to identify the knowledge levels of TB and investigate the factors associated with Cited by: 8.

Tuberculosis (TB) patients face numerous difficulties adhering to the long-term, rigorous TB treatment regimen. Findings on TB patients’ treatment adherence vary across existing literature and official reports. The present study attempted to determine the actual treatment adherence of new TB patients and to identify factors leading to non-adherence.

In India, each year, approx. deaths are reported due to n andthe disease cost Indian economy approximately USD 1 public health problem is the world's largest tuberculosis epidemic. India bears a disproportionately large burden of the world's tuberculosis rates, as it continues to be the biggest health problem in India.

Description Factors affecting treatment adherence in a tuberculosis population in Calcutta, India PDF

Treatment adherence was noted by screening treatment cards after any final outcome of the treatment as per Revised National Tuberculosis Control Program. Data were entered in Microsoft excel and analyzed using SPSS software (developed by IBM, Chicago, USA in ).

Results: Out of patients enrolled, could be : Priya Y Kulkarni, Atul D Kulkarni, Sulabha V Akarte, Prasad A Rajhans. Almost 33% of the world's population is thought to have been infected with Tuberculosis with new infections occurring in about 1% of the population each year.

Inthere were an estimated million chronic active cases globally, while inthere were an estimated million new cases and million associated deaths, mostly. Risk factors associated with default among tuberculosis patients in Darjeeling district of West Bengal, India Nirmalya Roy 1, Mausumi Basu 2, Sibasis Das 3, Amitava Mandal 4, Debashis Dutt 5, Samir Dasgupta 6 1 West Bengal Health Service, Burdwan District, India 2 Department of Community Medicine, Institute of Post-Graduate Medical Education and Research and Seth.

Background India with a major burden of multidrug-resistant tuberculosis (MDR-TB) does not have national level data on this hazardous disease. Sinceemergence of extensively drug-resistant TB (XDR-TB) is considered a serious threat to global TB control.

This study highlights the demographic and clinical risk factors associated with XDR-TB in by: hold environmental factors which enhance the risk of prevalence of Tuberculosis in India. Methods The present study utilized data from the fourth round of the National Family Health Survey (NFHS-4).

NFHS-4 provides district level estimates of important indicators on population, health and nutrition for India and each State / Union by: 1. The directly observed therapy-short course (DOTS) strategy was introduced in Shaanxi province, China to improve tuberculosis (TB) control by means of improved case detection (target: > = 70%) and treatment success rates (target: > = 85%) in new smear positive (SS+) TB patients.

At a provincial level the targets were both reached in Cited by: With an estimated new cases developing every year,1 multidrug-resistant tuberculosis is one of the greatest public health challenges worldwide. Multidrug-resistant tuberculosis is much more common in patients who have previously been treated for tuberculosis,1 and public health efforts have typically focused on high-quality treatment of drug-susceptible tuberculosis to Author: Anthony Fojo, David Wesley Dowdy.

Worldwide, there weremultidrug-resistant tuberculosis (MDR-TB) cases inand in the World Health Organization estimated thatdeaths occurred annually due to MDR-TB. Ethiopia is 15th among the 27 MDR-TB high-burden countries. This study identifies factors associated with the occurrence of MDR-TB in patients who underwent Cited by: Tuberculosis (TB) is the leading opportunistic disease and cause of death in patients with HIV infection.

In there were million new TB/HIV co-infected cases globally, accounting for 12% of incident TB cases and by:   The recrudescence of TB in India has been exacerbated by the emergence and spread of MDR-TB as well as the expanding HIV epidemic. With an estimated 2 million new cases of TB andTB-related deaths in India annually, India accounts for one-quarter of the global TB by: Quality of Tuberculosis Care in Urban Patna, India.

and (3) financial incentives to engaged providers for patient registration, diagnostic testing, treatment initiation, and treatment adherence. history questions asked by the practitioner during an interaction for tuberculosis benchmarked against the Standards of Tuberculosis Care in.

Globally in, people developed MDR-TB. TB incidence has fallen by % per year since and death rate dropped 47% between   Background Tuberculosis (TB), caused by Mycobacterium tuberculosis, is one of the leading causes of mortality and morbidity across all age groups throughout the world, especially in developing countries.

Methodology/Principal Findings In this study, we have included open index cases with their household contacts in a prospective cohort study. Tuberculosis (TB) is likely to have affected humans for most of their history (Holloway et al. ; Comas et al. ) and remains a major cause of death worldwide despite the discovery of effective and affordable chemotherapy more than 50 years million TB deaths (including TB deaths in HIV-positive individuals) in (), TB and the human.

Knowledge about symptoms and transmission of tuberculosis determines health seeking behavior and helps in prevention of tuberculosis transmission in the community. Such data is useful for policy makers to formulate information, education and communication strategies for tuberculosis control.

A secondary data analysis of India demographic and health survey, Cited by: FIGURE TB incidence rates are highest in young adults in the African and Southeast Asian regions. SOURCE: Swaminathan, In India, an estimated 7 percent of the reported million new TB cases annually are in children.

This percentage ranges from 2 percent of new smear-positive cases to 15 percent of new cases of extrapulmonary TB. Monday, Octo - Board 1 Abstract # Tuberculosis in India: A critical analysis Lynette J Menezes, MSW, Community and Family Health, University of South Florida, Bruce B.

Downs Blvd, Tampa, FL, [email protected] India has the largest number of tuberculosis cases in the world resulting in nearly. Tuberculosis is a major public health problem in India with more than 2 million new cases every year. With the growing crisis of inadequate healthcare workforce, monitoring of drug treatment for Tuberculosis is an arduous task.

mHealth services (healthcare using mobile communication technologies) are gaining support as an effective tool to handle the situation, Cited by: Directly-Observed and Self-Administered Tuberculosis Treatment in a Chronic, Low-Intensity Conflict Setting in India Mrinalini Das1, Petros Isaakidis1*, Edward Armstrong1, Nirmala Rani Gundipudi1, Ramesh B.

Babu2, Ihtesham A. Qureshi1, Andrea Claes1, Anil Kumar Mudimanchi1, Nagendra Prasad1, Homa Mansoor1, Sunita Abraham1 1Operational Research, Me´decins .